Wikimedia Commons
A US Food and Drug Administration (FDA) advisory committee just gave a critical recommendation for a version of Remicade, a drug used to treat autoimmune diseases like Crohn's disease and rheumatoid arthritis.
The independent panel voted 21-3 in favor of the drug, which was developed by Celltrion and goes by the name Remsima.
The drug is called a "biosimilar," which is like a generic version of a biologic medication, a medicine produced by living cells.
But it's a bit more complicated than that. Читать дальше...